Although LOXL2 has been widely studied in cancer and fibrotic diseases such as idiopathic pulmonary fibrosis, liver fibrosis, and cardiac fibrosis (34), its expression and function in AD were unclear. Here, LOXL2 is linked to pulmonary fibrosis.